<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0240">
 <label>48</label>
 <mixed-citation publication-type="other" id="or0010">F.-N. Hung, K.-C. Lung, R. Liu, W Chung, M. Chu, J. Chan, et al, Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, Lancet, 395 (2020) 1695–1704.</mixed-citation>
</ref>
